Pharmacogenomic

CYP2C19 Genotyping

Overview

Test Name

CYP2C19 Genotyping

Test Code

SG1005

Test Category

Single Gene Tests

Test Subcategory

Pharmacogenomic

Disease(s) Targeted

CYP2C19

Who Is The Test For?

Patients who may be prescribed certain drugs such as proton pump inhibitors, antiplatelet agents and antidepressants. To identify individuals who may be at risk with specific drug treatment.

No. of Variants

Variants

CYP2C9*2, CYP2C19*3, CYP2C19*17

Deliverables

Clinical Report (Download a sample report here)

Turnaround Time

2 weeks

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About CYP2C19

Variants of CYP2C19 gene can lead to altered drug metabolism. Impacting the effectiveness and safety of various medications. CYP2C19 polymorphisms influence the enzymes ability to process certain drugs, such as proton pump inhibitors, antiplatelet agents and antidepressants. These genetics differences may result in reduced or increased drug activity, potentially affecting treatment. Testing for these genetic differences allows the healthcare practitioner to determine treatment and monitoring strategies based on CYP2C19 status.